ATE337396T1 - Kombinatorische bibliotheken heteromerer cytotoxischer proteine - Google Patents
Kombinatorische bibliotheken heteromerer cytotoxischer proteineInfo
- Publication number
- ATE337396T1 ATE337396T1 AT98959689T AT98959689T ATE337396T1 AT E337396 T1 ATE337396 T1 AT E337396T1 AT 98959689 T AT98959689 T AT 98959689T AT 98959689 T AT98959689 T AT 98959689T AT E337396 T1 ATE337396 T1 AT E337396T1
- Authority
- AT
- Austria
- Prior art keywords
- heteromeric
- proteins
- cytotoxic proteins
- target cell
- combinatory libraries
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title abstract 3
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 231100000433 cytotoxic Toxicity 0.000 title 1
- 230000001472 cytotoxic effect Effects 0.000 title 1
- 102000008300 Mutant Proteins Human genes 0.000 abstract 1
- 108010021466 Mutant Proteins Proteins 0.000 abstract 1
- 239000003145 cytotoxic factor Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/25—Shigella (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1055—Protein x Protein interaction, e.g. two hybrid selection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Bioinformatics & Computational Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Plant Pathology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA002222993A CA2222993A1 (en) | 1998-02-04 | 1998-02-04 | A method for using a ribosome-inactivating protein complex as a structural template and a molecular search engine in the design, construction and screening of combinatorial protein libraries |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE337396T1 true ATE337396T1 (de) | 2006-09-15 |
Family
ID=4161822
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98959689T ATE337396T1 (de) | 1998-02-04 | 1998-12-08 | Kombinatorische bibliotheken heteromerer cytotoxischer proteine |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7713915B1 (de) |
| EP (1) | EP1051482B1 (de) |
| JP (1) | JP4339511B2 (de) |
| AT (1) | ATE337396T1 (de) |
| AU (1) | AU769824B2 (de) |
| CA (1) | CA2222993A1 (de) |
| DE (1) | DE69835695T2 (de) |
| WO (1) | WO1999040185A1 (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1727827B1 (de) * | 2004-03-26 | 2010-05-12 | Molecular Templates, Inc. | Bibliothek von toxin mutanten und deren verwendung |
| EP1945660B1 (de) | 2005-09-26 | 2014-05-07 | Molecular Templates, Inc. | Bibliothek aus toxinmutanten und verfahren zu deren anwendung |
| US20100298238A1 (en) * | 2007-10-08 | 2010-11-25 | Rutgers, The State University | Nontoxic shiga-like toxin mutant compositions and methods |
| EP2786147B1 (de) * | 2012-12-04 | 2017-02-01 | Scinopharm Taiwan Ltd. | Verfahren zur auswahl einer sammlung von molekülen |
| EP3666795A1 (de) | 2013-03-12 | 2020-06-17 | Molecular Templates, Inc. | Zytotoxische proteine mit zellgerichteten bindungsregionen und shigatoxin-a-untereinheitsregionen zur selektiven tötung von spezifischen zellarten |
| CN112851769A (zh) | 2014-01-27 | 2021-05-28 | 分子模板公司 | 用于哺乳动物中的去免疫化志贺毒素a亚基效应子多肽 |
| WO2015120058A2 (en) * | 2014-02-05 | 2015-08-13 | Molecular Templates, Inc. | Methods of screening, selecting, and identifying cytotoxic recombinant polypeptides based on an interim diminution of ribotoxicity |
| US11142584B2 (en) | 2014-03-11 | 2021-10-12 | Molecular Templates, Inc. | CD20-binding proteins comprising Shiga toxin A subunit effector regions for inducing cellular internalization and methods using same |
| CN106604934A (zh) | 2014-06-11 | 2017-04-26 | 分子模板公司 | 耐受蛋白酶切割的志贺毒素a亚基效应子多肽和包含其的细胞靶向分子 |
| EP3253799B1 (de) | 2015-02-05 | 2020-12-02 | Molecular Templates, Inc. | Multivalente cd20-bindende moleküle mit shigatoxin-a-untereinheiteffektorregionen und angereicherte zusammensetzungen davon |
| EP3303373B1 (de) | 2015-05-30 | 2020-04-08 | Molecular Templates, Inc. | Deimmunisierte shigatoxin-a-untereinheitsgerüste und zellgerichtete moleküle damit |
| KR20180030085A (ko) | 2015-07-26 | 2018-03-21 | 몰레큘러 템플레이츠, 인코퍼레이션. | 시가 독소 a 서브유닛 작동체 및 cd8+ t-세포 에피토프를 포함하는 세포-표적화 분자 |
| WO2018106895A1 (en) | 2016-12-07 | 2018-06-14 | Molecular Templates, Inc. | Shiga toxin a subunit effector polypeptides, shiga toxin effector scaffolds, and cell-targeting molecules for site-specific conjugation |
| MX2019008840A (es) | 2017-01-25 | 2019-09-09 | Molecular Templates Inc | Moleculas con direccion hacia las celulas que comprenden efectores de la sub-unidad a de la toxina shiga desinmunizados y epitopos de las celulas t cd8+. |
| CN110612117B (zh) | 2018-04-17 | 2024-04-12 | 分子模板公司 | 包含去免疫化的志贺毒素a亚基支架的her2靶向分子 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4753894A (en) * | 1984-02-08 | 1988-06-28 | Cetus Corporation | Monoclonal anti-human breast cancer antibodies |
| US5047513A (en) | 1986-07-10 | 1991-09-10 | Hoffmann-La Roche Inc. | Metal chelate resins |
| CA1340522C (en) | 1987-03-10 | 1999-05-04 | Heinz Dobeli | Fusion proteins containing neighbouring histidines for improved purification |
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| GB9109478D0 (en) * | 1991-05-02 | 1991-06-26 | Therapeutic Antibodies Inc | Antivenoms |
| JP3398957B2 (ja) * | 1991-12-24 | 2003-04-21 | ザ・プレジデント・アンド・フエローズ・オブ・ハーバード・カレツジ | Dnaの特定部位の突然変異誘発 |
| US5659123A (en) * | 1994-08-26 | 1997-08-19 | Plant Genetic Systems, N.V. | Diabrotica toxins |
| US5869250A (en) * | 1996-12-02 | 1999-02-09 | The University Of North Carolina At Chapel Hill | Method for the identification of peptides that recognize specific DNA sequences |
| US6086900A (en) | 1997-03-26 | 2000-07-11 | Board Of Regents, The University Of Texas Systems | Methods and compositions for using membrane-penetrating proteins to carry materials across cell membranes |
| US5888750A (en) | 1997-05-30 | 1999-03-30 | Synsorb Biotech, Inc. | Method of recovering shiga-like toxins and vaccines comprising inactivated shiga-like toxin |
| US20020161203A1 (en) * | 2000-08-14 | 2002-10-31 | Sheppard Paul O. | Rattlesnake venom gland proteins |
| US20030188326A1 (en) * | 2000-11-03 | 2003-10-02 | Dana Farber Cancer Institute | Methods and compositions for the diagnosis of cancer susceptibilities and defective DNA repair mechanisms and treatment thereof |
-
1998
- 1998-02-04 CA CA002222993A patent/CA2222993A1/en not_active Abandoned
- 1998-12-08 WO PCT/CA1998/001137 patent/WO1999040185A1/en not_active Ceased
- 1998-12-08 US US09/601,644 patent/US7713915B1/en not_active Expired - Fee Related
- 1998-12-08 JP JP2000530599A patent/JP4339511B2/ja not_active Expired - Fee Related
- 1998-12-08 AT AT98959689T patent/ATE337396T1/de not_active IP Right Cessation
- 1998-12-08 EP EP98959689A patent/EP1051482B1/de not_active Expired - Lifetime
- 1998-12-08 DE DE69835695T patent/DE69835695T2/de not_active Expired - Lifetime
- 1998-12-08 AU AU15530/99A patent/AU769824B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999040185A1 (en) | 1999-08-12 |
| US7713915B1 (en) | 2010-05-11 |
| DE69835695D1 (de) | 2006-10-05 |
| DE69835695T2 (de) | 2007-08-23 |
| CA2222993A1 (en) | 1999-08-04 |
| JP2002503453A (ja) | 2002-02-05 |
| AU769824B2 (en) | 2004-02-05 |
| EP1051482B1 (de) | 2006-08-23 |
| JP4339511B2 (ja) | 2009-10-07 |
| EP1051482A1 (de) | 2000-11-15 |
| AU1553099A (en) | 1999-08-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE337396T1 (de) | Kombinatorische bibliotheken heteromerer cytotoxischer proteine | |
| Seyedsayamdost et al. | Structure and biosynthesis of amychelin, an unusual mixed-ligand siderophore from Amycolatopsis sp. AA4 | |
| LU91759I2 (fr) | Denosumab et ses dérivés pharmaceutique acceptables (PROLIA®) | |
| AU1548795A (en) | Bacterial receptor structures | |
| AU2560599A (en) | Diagnosis and treatment of aur1 and/or aur2 related disorders | |
| AUPP344598A0 (en) | Continuous one step in-vitro evolution | |
| Chehade et al. | Design and synthesis of a transferable farnesyl pyrophosphate analogue to Ras by protein farnesyltransferase | |
| NZ335945A (en) | Presenilin proteins and genetic sequences that are related to Alzheimer's disease | |
| DE602004011770D1 (de) | Fusionsproteine | |
| FI925986A0 (fi) | Slumpartat bio-oligomer bibliotek, ett foerfarande foer syntetisering avdet samt ett foerfarande foer anvaendning av det | |
| DE69434166D1 (de) | Menschliche metabotropische glutamatrezeptor untertype hmglur7 und verwandte dns-verbindungen | |
| UA32548C2 (uk) | Ізольована послідовність днк, що кодує epsps фермент, ізольована послідовність днк, що кодує білок, який виявляє epsps активність, рекомбінантна двониткова молекула днк, спосіб одержання генетично трансформованих рослин | |
| NO20002787L (no) | Nye forbindelser | |
| ES2174075T3 (es) | Librerias combinatorias de compuestos bioquimicos marcados y metodos para producir las mismas. | |
| NO20000412L (no) | Dipeptidforbindelser som inhiberer leukocytt-adhesjon mediert av VLA-4 | |
| PT850310E (pt) | Molecula de dna circular com origem de replicacao condicional, metodo para a sua preparacao e utilizacao da mesma na terapia genica | |
| DK0745124T3 (da) | Pattedyr-cellecyklusprotein | |
| NO20021686D0 (no) | Fremgangsmåter for fremstilling av målemolekyler i et transgent dyr og rensing av målmolekylet | |
| EP1272609A4 (de) | Einkettige antikörper gegen eine p53 mutante | |
| BG101038A (bg) | Супресия на растежа на туморни клетки посредствомсиндекан- 1 ектоучастък | |
| ES2187648T3 (es) | Metodo para la administracion de farmacos para terapia genica. | |
| AU9363398A (en) | Hepatitis c receptor protein cd81 | |
| WO1996031603A3 (en) | Methods and compositions for regulating fadd | |
| CA2239282A1 (en) | Fused isoindolones as inhibitors of protein kinase c | |
| WO2001064876A3 (en) | Human schizophrenia gene |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |